Frontlight ResearchEarly access
Taking people in United StatesPhase 3
Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement
Key facts
- Who runs it
- Rutgers, The State University of New Jersey
- Where
- New Brunswick and Salt Lake City, United StatesSee the 2 sites
- Trial code
- Status
- Recruiting
- Phase
- Phase 3
- People taking part
- 420 people, planned
- Started
- 5 Sept 2023
- Expected to end
- Aug 2028
- Type of study
- Interventional, 4 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- MORE and MI and NRT
- MORE and No MI and NRT
- Support Group and MI and NRT
- Support Group and No MI and NRT
- Record updated
- 17 July 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- English-speaking
- Age ≥18
- Currently on methadone; and 4) currently smoke cigarettes
Who cannot take part
- Previous formal mindfulness training (e.g., MBSR, MBRP) or MORE (from the R21 or R33
- Currently taking smoking cessation pharmacotherapy or participating in smoking cessation counseling
- Severe cognitive impairment (score >23 on Mini Mental Status Exam) or psychosis (positive SCID Psychotic Screen)
- Suicidal risk (score ≥7 on Suicidal Behaviors Questionnaire)
- Inability to attend or fully participate in intervention sessions or assessments
- Any contraindications for NRT
- Currently or soon planning to be pregnant or breastfeeding
This trial is currently available in United States.
- Rutgers, Robert Wood Johnson Medical SchoolNew Brunswick, United StatesContact: Nina CoopermanTaking people
- University of UtahSalt Lake City, United StatesContact: Eric Garland, PhDTaking people
About the trial
What the trial wants to find out
The purpose of this study is to 1) examine barriers and facilitators to implementation of MI and MORE for polysubstance use and evaluate strategies for optimizing training, fidelity, and clinic uptake, and 2) evaluate patient outcomes related to the effectiveness of MORE decreasing opioid, tobacco, and other drug use.
The 4 groups in the trial
- MORE and MITreatment being tested
Treatment: MORE and MI and NRT
- MORE and No MITreatment being tested
Treatment: MORE and No MI and NRT
- Support Group and MIExisting treatment, for comparison
Treatment: Support Group and MI and NRT
- Support Group and No MIExisting treatment, for comparison
Treatment: Support Group and No MI and NRT
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Motivational Interviewing (MI) and Mindfulness-Oriented Recovery Enhancement (MORE) for Tobacco Dependence and Other Drug Use in Methadone Treatment
- Record updated
- 17 July 2026